Patient characteristics promoting lipidic coronary plaque

Exploring Risk Factors Promoting Lipidic coronary plaque formation - Risk Factors Promoting Lipidic coronary plaque formation

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000050813

Enrollment

1000

Registered

2023-04-19

Start date

2023-04-20

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coronary Artery Disease

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Patients who scheduled percutaneous coronary intervention (PCI) due to coronary artery disease 2. NIRS-IVUS is planned to use as an intravascular imaging device during PCI

Exclusion criteria

Exclusion criteria: Patients considered not eligible for the study by the attending doctor due to other reasons

Design outcomes

Primary

Measure	Time frame
Impact of blood inframmatroy markers (IL-1, IL-18 and TNF-alpha) on vulnerability of coronary culprit lesion(max lipid core burden index)	—

Secondary

Measure	Time frame
1. Impact of conventional coronary risk factors (hypertension, diabetes, dyslipidemia, smoking history, body mass index and famaily history) on vulnerability of coronary culprit and non-culprit lesion 2. Impact of blood inframmatroy markers (IL-1, IL-18 and TNF-alpha) on vulnerability of coronary non-culprit lesion(max lipid core burden index) 3. Exploring predictive model using plaque charcterization and patient characteristics	—

Measure

Time frame

1. Impact of conventional coronary risk factors (hypertension, diabetes, dyslipidemia, smoking history, body mass index and famaily history) on vulnerability of coronary culprit and non-culprit lesion 2. Impact of blood inframmatroy markers (IL-1, IL-18 and TNF-alpha) on vulnerability of coronary non-culprit lesion(max lipid core burden index) 3. Exploring predictive model using plaque charcterization and patient characteristics

—

Countries

Japan

Contacts

Public ContactTakashi Kuwano

Fukuoka University School of Medicine Department of Cardiology

tkuwano@fukuoka-u.ac.jp092-801-1011

Outcome results